前立腺がんの統計,2025年
Tyler B Kratzer1, Natalia Mazzitelli1, Jessica Star1
1Surveillance and Health Equity Science, American Cancer Society, Atlanta, Georgia, USA.
CA: a cancer journal for clinicians
|September 2, 2025
まとめ
前立腺がんの発生率は上昇しています 特に若い男性では 進行段階です 早期発見と公平な治療の必要性を強調しています.
科学分野:
- 腫瘍学
- エピデミオロジー
- 公衆衛生
背景:
- 前立腺がんは米国男性で最も一般的な癌です.
- 先進的な前立腺がんの発生率は急速に増加しています.
- 前立腺がんの発症率は 人種差異が顕著です
研究 の 目的:
- 前立腺がんの発生率と死亡率の傾向を分析する.
- ステージ,年齢,人種/民族によって傾向を調べる.
- 格差を特定し,公衆衛生戦略を策定する.
主な方法:
- 集団ベースの発生率と死亡率のデータを使用した.
- データソースには,国立がん研究所とCDCが含まれています.
- 分析は2007年から2021年の動向を対象とし,人口統計と疾患の段階によって層分かれました.
主要な成果:
- 前立腺がんの発生率は減少から3.0%の年間増加 (2014-2021年) に逆転した.
- 若い男性では遠隔期疾患,年配の男性では地域/遠隔期疾患の増加傾向が顕著です.
- 人種差は,アメリカン・インディアン/アラスカ・ネイティブ,アジア系アメリカン/太平洋島民,ヒスパニック系男性における局所的な診断率が低く,アメリカン・インディアン/アラスカ・ネイティブおよび黒人男性における死亡率が高い.
結論:
- 進行性前立腺がんの診断の増加と 人種差異の持続は 早期発見の努力を強化することを必要としています
- 戦略は過剰な診断と 公平な前立腺がん診断の障害に対処しなければなりません
- これらの傾向を緩和するには 緊急の公衆衛生介入が必要です
関連する概念動画
Cancer Survival Analysis
448
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
448
Disorders of the Male Reproductive System
570
Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
570
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
Cancer Vaccines
509
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
509
Menopause
248
Menopause, a natural biological process marking the end of a woman's fertility, typically occurs between the fifth and sixth decade of life. This phase is characterized by the exhaustion of the ovarian follicle pool, leading to less responsive ovaries despite the high levels of Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH). The consequential decrease in estrogen production results in symptoms like hot flashes, heavy sweating, headaches, hair loss, muscle pains, vaginal...
248
Tumor Progression
6.5K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.5K


